GeneDx CEO on q3 earnings beat, genetic testing and pediatric health

Katherine Stueland, GeneDx CEO, joins 'Closing Bell' to discuss the company's q3 earnings beat, genetic testing and pediatric health.

featured-image

Katherine Stueland, GeneDx CEO, joins 'Closing Bell' to discuss the company's q3 earnings beat, genetic testing and pediatric health..